Detalles de la búsqueda
1.
Sustained Responses of Neutralizing Antibodies Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Recovered Patients and Their Therapeutic Applicability.
Clin Infect Dis;
73(3): e550-e558, 2021 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32898238
2.
Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
J Virol;
94(24)2020 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32967955
3.
Sequential Emergence and Wide Spread of Neutralization Escape Middle East Respiratory Syndrome Coronavirus Mutants, South Korea, 2015.
Emerg Infect Dis;
25(6): 1161-1168, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30900977
4.
IL-7-primed bystander CD8 tumor-infiltrating lymphocytes optimize the antitumor efficacy of T cell engager immunotherapy.
Cell Rep Med;
5(5): 101567, 2024 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38744277
5.
Rise in broadly cross-reactive adaptive immunity against human ß-coronaviruses in MERS-recovered patients during the COVID-19 pandemic.
Sci Adv;
10(9): eadk6425, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38416834
6.
Enhancing immune protection against MERS-CoV: the synergistic effect of proteolytic cleavage sites and the fusion peptide and RBD domain targeting VLP immunization.
Front Immunol;
14: 1201136, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37275866
7.
Corrigendum: Differential association of viral dynamics with disease severity depending on patients' age group in COVID-19.
Front Microbiol;
14: 1178685, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37007516
8.
Elevated IFNA1 and suppressed IL12p40 associated with persistent hyperinflammation in COVID-19 pneumonia.
Front Immunol;
14: 1101808, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36776879
9.
Corrigendum: Elevated IFNA1 and suppressed IL12p40 associated with persistent hyperinflammation in COVID-19 pneumonia.
Front Immunol;
14: 1175767, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36969212
10.
Protective and pathogenic role of humoral responses in COVID-19.
J Microbiol;
60(3): 268-275, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35235178
11.
Eosinophil-mediated lung inflammation associated with elevated natural killer T cell response in COVID-19 patients.
Korean J Intern Med;
37(1): 201-209, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34565131
12.
Longevity of seropositivity and neutralizing antibodies in recovered MERS patients: a 5-year follow-up study.
Clin Microbiol Infect;
28(2): 292-296, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34139334
13.
Inducing Ectopic T Cell Clusters Using Stromal Vascular Fraction Spheroid-Based Immunotherapy to Enhance Anti-Tumor Immunity.
Adv Sci (Weinh);
9(28): e2203842, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36058002
14.
A Hepatitis B Virus-Derived Peptide Can Inhibit Infection of Human Lung Cells with SARS-CoV-2 in a Type-1 Interferon-Dependent Manner.
Viruses;
13(7)2021 06 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34202029
15.
Differential Association of Viral Dynamics With Disease Severity Depending on Patients' Age Group in COVID-19.
Front Microbiol;
12: 712260, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34367117
16.
Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19.
Cell Rep;
37(1): 109798, 2021 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34587481
17.
Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein.
Virus Res;
278: 197863, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31945421
18.
Erratum to: Protective and Pathogenic Role of Humoral Responses in COVID-19.
J Microbiol;
61(7): 713, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37530961
19.
Reduction of soluble dipeptidyl peptidase 4 levels in plasma of patients infected with Middle East respiratory syndrome coronavirus.
Virology;
518: 324-327, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29587190
Resultados
1 -
19
de 19
1
Próxima >
>>